Human Papillomavirus DNA Testing in Routine Clinical Practice for Prediction of Underlying Cervical Intraepithelial Neoplasia 2/3+ at Initial Evaluation and in Follow-up of Women with Atypical Glandular Cell Papanicolaou Tests